3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
36
Carcinoma, Non-Small-Cell Lung
17
Small Cell Lung Carcinoma
16
Neoplasms
14
Lung Neoplasms
13
Breast Neoplasms
7
Melanoma
6
Colorectal Neoplasms
6
Carcinoma, Renal Cell
6
Liver Neoplasms
5
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Prostatic Neoplasms
4
Neoplasm Metastasis
4
Head and Neck Neoplasms
4
Glioblastoma
4
Endometrial Neoplasms
4
Sarcoma
3
Recurrence
3
Neoplasms by Site
3
Neoplasms by Histologic Type
3
Carcinoma, Transitional Cell
3
Uterine Cervical Neoplasms
2
Urogenital Neoplasms
2
Small Cell Lung Cancer Extensive Stage
2
Sarcoma, Alveolar Soft Part
2
Ovarian Neoplasms
2
Osteosarcoma
2
Mesothelioma, Malignant
2
Mesothelioma
2
Interventions
Imatinib Mesylate
8
Sunitinib
3
ripretinib
2
regorafenib
2
apatinib
2
IDRX-42
2
trastuzumab deruxtecan
1
pemigatinib
1
olverembatinib
1
envafolimab
1
atezolizumab
1
Temozolomide
1
Surgical Instruments
1
Quality Assurance, Health Care
1
Paclitaxel
1
Observation
1
Neoadjuvant Therapy
1
Liquid Biopsy
1
Dasatinib
1
Blood Specimen Collection
1
4-Aminopyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Gastrointestinal Stromal Tumors
×
atezolizumab
×
Clear all
NCT05152472
2026-04-24
ATEZOGIST
Centre Leon Berard
Phase 2
Recruiting
110 enrolled